Sciclone Pharma (SCLN) Tops Q2 EPS by 14c

August 10, 2015 4:02 PM EDT

Sciclone Pharma (NASDAQ: SCLN) reported Q2 EPS of $0.26, $0.14 better than the analyst estimate of $0.12. Revenue for the quarter came in at $37.9 million versus the consensus estimate of $37.27 million.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings